NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

No private placements until clinical data release

NWBO not selling shares since data lock and most probably not until TLD does not have anything to do with the conditions of those notes but more with the quiet period they have stated they are in and NWBO, most probably, not being eligible to issues shares under their S-3 due to their late SEC filings from last year.

Those notes just state that the lender and NWBO have agreed that the lenders have the right to after the release of clinical trial data and a next private placement offering buy shares at a 12% discount equal to an amount up to 50% of the loan and exchange some or all of the outstanding loan amount for a variable number of shares, within seven days after the Next at a 12% discount.

NWBO does not commit itself in that loan agreement to not sell shares before TLD.

The good news is that NWBO does acknowledge that there is such thing as the release of clinical trial data (insight for the lenders) and that the lenders can exchange notes for shares after TLD if in fact, that happens before Nov 1.

If NWBO does not release trial data before Nov 1 2021 then NWBO has intentionally forfeited a big part of the reward for the lenders which is the exchange of the principal amount of the notes against shares at a 12% discount which would, in fact, be a big F... you from NWBO to these Lenders. IMO